Cell cluster spheroid three-dimensional culture plate TASCL 6WELL
TASCL 6WELL 1000／TASCL 6WELL 600
It is easy to culture three-dimensional cell aggregates (spheroids) with almost uniform shape and size. Differentiation induction is also possible through long-term culture. The usage is simple.
The features of the three-dimensional cell aggregate (spheroid/embryoid body) culture and differentiation induction microplate "TASCL" are as follows: 1. It allows for the mass three-dimensional culture of cell aggregates with nearly uniform shape, size, and quality at once. Approximately 600 cell aggregates can be cultured in TASCL 6WELL 600, and about 1000 in TASCL 6WELL 1000. 2. The bottom surface of the micro-well is perforated, enabling the circulation of culture media and gases to the cells through the culture insert, allowing for prolonged and optimal culture of the cell aggregates. 3. Long-term culture of cell aggregates for more than one month is possible, and differentiation induction can be performed using the same equipment. 4. The high-density well structure reduces the amount of culture media and reagents needed, leading to savings. 5. The wells are treated with a cell adhesion-inhibiting coating (valid for two years from the date of manufacture). They are gamma-irradiated, allowing for immediate use upon opening. 6. Cell seeding is simply done by evenly dropping a cell suspension from above. Centrifugation is unnecessary, and media exchange is also easy. 7. Made from a permeable material, it allows for the observation of cells using an inverted microscope from the bottom while culturing cells in TASCL.
Inquire About This Product
basic information
The usage is simple; just seed the cell suspension from the top (no centrifugation needed), and the cells will settle into each well. The tip is sharp, preventing cell blockage. The structure is angled, narrowing at the bottom, allowing cell aggregates to be cultured within this well. The bottom is perforated, and when used on the included culture insert, it allows for the circulation of gas and medium, maintaining optimal cell conditions. Each set includes a 6WELL plate with 6 culture inserts and 6 TASCLs. The TASCLs are treated to prevent cell adhesion (effective for one year from manufacturing), and the entire set is sterilized and packaged. It can be used immediately after opening. Sales will resume in February 2024.
Price information
Open price (please inquire)
Price range
P2
Delivery Time
P3
※It depends on the stock and the order quantity.
Applications/Examples of results
【Cluster culture confirmed】 ■Human iPS cells ■Human adipose-derived stem cells ■Mouse ES cells ■Mouse adipose-derived stem cells ■Mouse hepatocytes ■HepG2 cells ■NIB6 cells, etc. *For more details, please download the PDF or contact us.
Detailed information
-
TASCL micro well plate
-
Structure of TASCL (enlarged view)
-
Structure of TASCL (Cross-sectional view image)
-
hiPS cells
-
Cell aggregates cultured in TASCL.
-
Cell aggregates cultured with TASCL (fluorescent Q-dot)
-
Two micro well sizes of TASCL
-
Size distribution of cell aggregates cultured in TASCL.
Line up（2）
| Model number | overview |
|---|---|
| TASCL 6WELL 1000 | Regarding the micro well (one TASCL micro well plate), main body: circular with a diameter of 23.5mm, micro well part: 16.65 square mm, number of micro wells: 1020, micro well top: 500μm×500μm, micro well bottom: 250μm×250μm, micro well height: 500μm, estimated number of cultured cells per well: 500 to 3000 cells |
| TASCL 6WELL 600 | Regarding the micro well (one TASCL micro well plate), main body: circular with a diameter of 23.5mm, micro well part: 16.65 square mm, number of wells: 621, well top: 650μm×650μm, well bottom: 400μm×400μm, well height: 500μm, estimated number of cultured cells per well: 2,000 to 10,000 cells |
catalog（2）
Download All Catalogs
News about this product（3）
Company information
Simus Bio Co., Ltd. is engaged in the promotion of three-dimensional cell aggregate culture technology, the advancement of research using cell aggregates, and the development of new treatment methods for regenerative medicine.